Generic Lipitor Supply Adequate as Ranbaxy Recalls Pills

Ranbaxy Laboratories Ltd.’s recall and production halt of its version of the cholesterol pill Lipitor won’t create a supply shortage, U.S. regulators said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.